Literature DB >> 12708901

Cytokeratin 19 immunolocalization in cell block preparation of thyroid aspirates. An adjunct to fine-needle aspiration diagnosis of papillary thyroid carcinoma.

Kamal K Khurana1, Luan D Truong, Virginia A LiVolsi, Zubair W Baloch.   

Abstract

CONTEXT: Immunohistochemical staining for cytokeratin 19 (CK-19) is a useful ancillary technique for diagnosing papillary thyroid carcinoma (papillary carcinoma) in histologic specimens. Although similar results have been obtained on aspirate smears, to our knowledge the utility of CK-19 immunolocalization in cell block preparations as an adjunct to fine-needle aspiration diagnosis of papillary carcinoma has not been examined.
OBJECTIVE: The purpose of this study was to determine whether CK-19 immunostaining of cell block preparations of thyroid aspirates is a useful ancillary technique for diagnosing papillary carcinoma.
MATERIALS AND METHODS: Using a monoclonal antibody to CK-19 and a standard avidin-biotin complex technique, immunostaining was performed on paraffin-embedded cell blocks of 57 cases with the following cytologic diagnoses: (a) papillary carcinoma (20 cases); (b) atypical cytology, cannot exclude papillary carcinoma (19 cases); and (c) nonneoplastic thyroid (18 cases). The staining reaction in each case was graded on the basis of percentage of epithelial cells stained (1+, <10%; 2+, <10%-50%; 3+, >50). Tissue follow-up was available in all cases.
RESULTS: Nineteen (95%) of 20 cases with an unequivocal diagnosis of papillary carcinoma were positive for CK-19 (3+). Tissue follow-up confirmed papillary carcinoma in all 20 cases. Of the 19 cases with a diagnosis of atypical cytology, cannot exclude papillary carcinoma, 7 (37%) cases displayed 3+ immunostaining and subsequent excision confirmed papillary carcinoma in all 7 cases. The remaining 12 cases with 1+ immunostaining included surgically confirmed goiter (6 cases), adenoma (2 cases), lymphocytic thyroiditis (3 cases), and papillary carcinoma (1 case). The follicular cells in 18 cases with a cytologic diagnosis of nonneoplastic thyroid showed 1+ immunostaining. Histologic follow-up of these cases confirmed the nonneoplastic cytologic diagnoses.
CONCLUSIONS: Cytokeratin 19 immunostaining of cell block preparations of thyroid aspirates serves as a useful tool for the diagnosis of papillary carcinoma. Strong immunostaining (3+) for CK-19 aids in accurate diagnosis of malignancy in cytomorphologically equivocal cases of papillary carcinoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12708901     DOI: 10.5858/2003-127-0579-CIICBP

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  5 in total

1.  The diagnostic accuracy of the immunocytochemical markers in the pre-operative evaluation of follicular thyroid lesions.

Authors:  E Raggio; M Camandona; D Solerio; P Martino; A Franchello; F Orlandi; G Gasparri
Journal:  J Endocrinol Invest       Date:  2009-07-21       Impact factor: 4.256

2.  HBME1 and CK19 expression in non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) vs other follicular patterned thyroid lesions.

Authors:  Qandeel Sadiq; Radhika Sekhri; Daniel T Dibaba; Qi Zhao; Shweta Agarwal
Journal:  World J Surg Oncol       Date:  2021-05-08       Impact factor: 2.754

3.  Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules.

Authors:  Leslie R Rowe; Brandon G Bentz; Joel S Bentz
Journal:  Cytojournal       Date:  2006-04-10       Impact factor: 2.091

4.  Differential expression of galectin-3, CK19, HBME1, and Ret oncoprotein in the diagnosis of thyroid neoplasms by fine needle aspiration biopsy.

Authors:  Husain A Saleh; Jining Feng; Farah Tabassum; Opada Al-Zohaili; Muji Husain; Tamara Giorgadze
Journal:  Cytojournal       Date:  2009-09-18       Impact factor: 2.091

5.  Value of cytokeratin-19, Hector Battifora mesothelial-1 and galectin-3 immunostaining in the diagnosis of thyroid neoplasms.

Authors:  Rajasekhar Sanuvada; Rukmangadha Nandyala; Amit Kumar Chowhan; Phaneendra Bobbidi; Mutheeswariah Yootla; Narendra Hulikal; Alok Sachan
Journal:  J Lab Physicians       Date:  2018 Apr-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.